1. |
Surgery: Clinical Studies Open For Enrollment Medtronic EndurAnt Stent Graft system vs ExcluDer endoprothesis: a global, prospectiVe, rANdomized Clinical trial in sac rEgression (ADVANCE Study) Prospective Randomized Open Label Multicenter Phase IV Clinical Trial to Compare Transforming Powder Dressing (TPD) to Current Standard of Care (SOC) Dressing Therapies in Acute Partial Thickness Burn Wounds Randomized, Controlled, Open-Label, Parallel Group, Multi-Center, Prospective Phase 4 Study Compari...
- Site Map Content
- 6/13/2025
|
2. |
Cardiology: Clinical Studies Open For Enrollment PROTOCOL CY 6022 AN OPEN-LABEL STUDY OF CK3773274 FOR PATIENTS WITH SYMPTOMATIC HYPERTROPHIC CARDIOMYOPATHY (HCM) Observational Study Protocol CV027-012 DELIVER INSIGHTS IN HYPERTROPHIC CARDIOMYOPATHY AND OBSERVATIONAL OUTCOMES IN REAL WORLD (DISCOVER-HCM): UNITED STATES PROSPECTIVE REGISTRY STUDY A multi-center, randomized, double-blind, placebo-controlled, parallel-group Phase IIIb study evaluating the effect of inclisiran on atherosclerotic plaque prog...
- Site Map Content
- 5/15/2025
|
3. |
Hematology: Clinical Studies Open For Enrollment Allogeneic Stem Cell Transplant to Induce Mixed Donor Chimerism in Patients with Sickle Cell Disease & Thalassemia NYMC 556 The use of dose dense rituximab for high risk patients with newly diagnosed acute immune thrombocytopenic purpura NYMC-598, A Phase II Trial of Targeted Immunotherapy with Daratumumab Following Myeloablative Total Body Irradiation (TBI)-Based Conditioning and Allogeneic Hematopoietic Cell Transplantation in Children, Adolesc...
- Site Map Content
- 6/13/2025
|
4. |
Welcome! Please View Our Campus Tour
- Site Map Content
- 10/3/2024
|
5. |
Oncology: Clinical Studies Open For Enrollment Lymphoma Leukemia Solid Tumors Brain Tumors Radiation Medicine Transplants Myeloma Sarcoma Mesothelioma Non-Small-Cell Lung Pediatrics Lymphoma Immunochemotherapy with Obinutuzumab, Ifosfamide, Carboplatin and Etoposide (O-ICE) in CAYA with recurrent refractory CD20+ Mature B-NHL Pilot Study Using Induction Chemo-immunotherapy followed by Consolidation with Reduced Toxicity Conditioning and Allogenic Stem Cell Transplant in Advanced Sta...
- Site Map Content
- 6/2/2025
|